Atlas Trials

A Study to Compare Taspoglutide and Insulin Glargine in Insulin-Naïve Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin and Sulfonylurea Combination Therapy

Clinical trial NCT01051011 · TERMINATED

Trial details

NCT number
NCT01051011
Sponsor
Hoffmann-La Roche
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Diabetes Mellitus Type 2
Start date
2010-01-01
Primary completion
2010-12-01
Enrollment
370

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.